Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamine for Prevention of Bortezomib-induced Peripheral Neuropathy in Multiple Myeloma
NCT01783522Phase 2Terminated
- Start
- Feb 2013
- Primary completion
- Nov 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of glutamine in peripheral neuropathy. Started Feb 2013; status: terminated.
02
Drugs
glutamine
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT01783522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01783522.